؉ antiporter are predicted to be close to each other on the basis of disulfide cross-linking experiments of the double-cysteine mutants in the periplasmic loop regions (Kubo, Y., Konishi, S., Kawabe, T., Nada, S., and Yamaguchi, A. (2000) J. Biol. Chem. 275, 5270 -5274). In this study, each amino acid from Asn-2 to Gly-44 in the putative TM1 and loop1-2 regions or that from Ser-328 to Gly-366 in TM11 and its flanking regions was individually replaced with cysteine. With respect to the TM1 region, 10 mutants, from T5C to L14C, were all not reactive with N-ethylmaleimide (NEM), and from D15C to I22C, NEM-reactive and non-reactive mutations periodically appeared every two residues. Three mutants, M23C to V25C, were all NEM-reactive, but the degree of the latter two mutants was very low. Seven mutants, from L26C to E32C, were all highly reactive with NEM. Therefore, the region of TM1 is composed of the 21 amino acid residues from Thr-5 to Val-25. It is a partially amphiphilic helix, that is, the N-terminal (cytoplasmic) half is embedded in the hydrophobic interior, and the C-terminal (periplasmic) half faces a waterfilled channel. With respect to TM11, nine mutants, from S328C to G336C, and six mutants, from L361C to G366C, were all reactive with NEM. On the other hand, out of the 24 mutants, from L337C to S360C, 17 were not reactive with NEM, and the 7 NEM-reactive mutants were scattered, indicating that this region is a transmembrane segment. The 7 residues from Val-347 to Phe-353 including Pro-350 formed a central hydrophobic core, and the 7 NEM-reactive mutations were periodically distributed in its flanking regions, indicating that both ends of TM11 face a water-filled channel. Ala-354 is located at about 1/3 of the length from the periplasmic end of TM11. Disulfide cross-linking experiments on doublecysteine mutants having the combination of A354C and a cysteine-scanning mutation in the loop1-2 region indicated that loop1-2 is very flexible and close to the periplasmic end of TM11. Tetracycline prevented the cross-linking formation between the periplasmic ends of TM1 and TM11; however, it did not affect the crosslinking between loop1-2 and TM11, indicating that the substrate-induced conformational change involves a shift in the relative locations of TM1 and TM11.
cross-linking formation between the periplasmic ends of TM1 and TM11; however, it did not affect the crosslinking between loop1-2 and TM11, indicating that the substrate-induced conformational change involves a shift in the relative locations of TM1 and TM11.
The transposon Tn10-encoded metal-tetracycline/H ϩ antiporter TetA(B) (2, 3) has been studied as a paradigm of antiporters belonging to a major facilitator superfamily (MFS). Its 12-membrane-spanning structure was at first determined on the basis of the results of hydropathy analysis and limited protease digestion (4) . Afterward, the 12-membrane-spanning structure of TetA(C), which is a homolog of TetA(B) encoded by pBR322, was confirmed by a PhoA fusion experiment (5) . We finally established the topology of TetA(B) by means of sitedirected competitive chemical modification of cysteine-introduced mutants, in which a cysteine residue was introduced into each putative loop region of the cysteine-free TetA(B), with membrane-permeable and -impermeable maleimide derivatives using whole mutant TetA(B) proteins retaining normal transport activity (6) . Taking advantage of the difference in reactivity between SH groups in hydrophilic and hydrophobic environments with N-ethylmaleimide (NEM), 1 the detailed boundaries between transmembrane segments and mediumexposed loop regions were determined in putative transmembrane segments (TM) 9 (7), 3 (8), 2 (9), and 6 (10). TM3, 6, and 9 were totally embedded in the hydrophobic interior of the membrane, and thus, none of the cysteine-scanning mutants in these transmembrane regions were reactive with NEM (7, 8, 10) . A similar SH-reagent non-reactive nature of cysteine-scanning mutants of transmembrane segments has also been reported for an erythrocyte anion exchanger (11) and Escherichia coli multidrug exporter EmrE (12) . On the other hand, TM2 is amphiphilic, that is, one side of its helix faces a water-filled transmembrane channel (9) . Very recently, we found that TM5 also comprises amphiphilic helices facing a water-filled channel and that the water-filled channel has a permeability barrier for solutes in the middle of the membrane (13) .
Second-site suppressor mutation studies reveal that both the cytoplasmic and periplasmic ends of putative TM1 and TM11 are conformationally linked to each other (14) . Cross-linking experiments on disulfide mutants in which two cysteine residues were introduced into any two putative periplasmic loop regions of TetA(B) confirmed that the periplasmic ends of TM1 * This work was supported by Grants-in-aid from the Ministry of Education and the Ministry of Science and Technology of Japan. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
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** To whom correspondence should be addressed: Institute of Science and Industrial Research, Osaka University, 8-1 Mihogaoka, Ibarakishi, Osaka 567-0047, Japan. Tel.: 81-6-6879-8545; Fax: 81-6-6879-8549; E-mail: akihito@sanken.osaka-u.ac.jp. and 11 are close to each other (1) . In this study, in order to determine the precise boundaries of TM1 and TM11 and the detailed spatial relationship between loop1-2 and TM11, cysteine-scanning mutants were constructed as to TM1 and TM11 and their flanking regions (Fig. 1) . As a result, the boundaries of TM1 and TM11 were changed from the originally estimated ones on the basis of the hydropathy profile. Leu-30 and Ala-354, which had been estimated to be located at the periplasmic ends of TM1 and TM11, respectively (14) , were revealed to be located at about the N-terminal half of loop1-2 and in the transmembrane region of TM11, respectively. Loop1-2 seems to protrude into a water-filled channel and to be close to TM11.
EXPERIMENTAL PROCEDURES

Materials-N-[ethyl-1-
14 C]Maleimide (NEM) (1.5 GBq/mmol) was purchased from NEN Life Science Products. All other materials were of reagent grade and obtained from commercial sources.
Site-directed Mutagenesis-Cysteine-scanning mutants were constructed by oligonucleotide-directed site-specific mutagenesis according to the method of Kunkel (15) using synthetic oligonucleotides. For the mutagenesis, plasmid pCTC377A (7), which carries the 2.45-kilobase Cys-less Tn10 tetA and tetR gene fragments, was used as a template. All of the mutations were detected as the appearance of a newly introduced restriction site and then verified by DNA sequencing in the region of the restriction fragments, which had been transferred to low copy number plasmids.
Low copy number mutant plasmids were constructed through the exchange of BglII-EcoRV fragments (TM1) or EcoRI-BamHI fragments (TM11) of the Cys mutants with the corresponding fragments of the low copy number plasmid, pLGC377A, which encodes a cysteine-less mutant of TetA(B) (7), and then used for tetA(B) gene expression.
Determination of Tetracycline Resistance-Tetracycline resistance was determined by means of a 2-fold agar dilution method as described previously (16) and expressed as the minimum inhibitory concentration.
Assay of the Reaction of [ 14 C]N-Ethylmaleimide with TetA(B) Proteins-The [
14 C]NEM binding experiment was performed using sonicated membranes prepared from E. coli W3104 cells carrying one of the derivatives of pLGC377A as described previously (17) . After solubilization and immunoprecipitation with anti-TetA(B) C-terminal antiserum (18) and Pansorbin Staphylococcus aureus cells (19) followed by SDS gel electrophoresis, the protein bands and the radioactive bands were visualized by Coomassie Brilliant Blue staining and with a BAS-1000 Bio-Imaging Analyser (Fuji Film Co., Ltd., Tokyo), respectively.
Prevention of [ 14 
C]NEM Binding by 4-Acetamido-4Ј-maleimidylstilbene-2-2Ј-disulfonic acid (AMS)-Prevention of [
14 C]NEM binding by AMS was measured in intact cells as described previously (6) .
Construction of Double-Cys Mutants-Double-Cys mutants were constructed by the recombination of a BglII-EcoRI fragment of each singleCys mutant gene in TM1 or the loop1-2 region with the corresponding fragment of the A354C mutant gene in the low copy number plasmid. The resulting mutants were confirmed by restriction analysis using restriction sites introduced to site-directed Cys mutagenesis sites through a silent mutation.
Gel-shift Assaying of Disulfide Cross-linking-Disulfide cross-linking was detected as a mobility shift on SDS gel electrophoresis after oxidation with Cu 2ϩ /o-phenanthroline, as described previously (1). As a control, the sulfhydryl groups of the double-Cys mutants were masked by preincubation with excess NEM before the cross-linking reaction.
RESULTS
Drug Resistance Levels of the Cysteine-scanning Mutants-
The S4C (6), R31C to G44C (9), L29C, L30C (20) , G332C, A354C (14) , S328C, Y357C, S360C, and D365C (6) mutants were constructed previously. The other 59 mutants were constructed in this study. With respect to TM1 and the loop1-2 region, no mutants completely lost the tetracycline resistance (Table I) . Asp-15 is one of three transmembrane-conserved acidic residues, and its mutation to Asn drastically reduced the resistance (21); however, the D15C mutant retained the wildtype resistance level. Only two mutants, P24C and G44C, exhibited largely reduced resistance (6.3 and 12.5 g/ml, respectively). The reduction of the resistance of these mutants is probably due to structural distortion. In addition, G18C, G20C, and D38C exhibited moderate resistance (50 g/ml). The other 200  S3C  200  L26C  200  S4C  200  P27C  100  T5C  100  T28C  200  K6C  100  L29C  200  17C  100  L30C  200  A8C  200  R31C  200  L9C  200  E32C  200  V10C  200  F33C  200  I11C  200  I34C  200  T12CC  200  A35C  200  L13C  200  S36C  200  T14C  200  E37C  200  D15C  200  D38C  50  A16C  100  I39C  200  M17C  200  A40C  100  G18C  50  N41C  100  I19C  200  H42C  100  G20C  50  F43C  100  L21C  200  G44C 12.5 I22C 200
FIG. 1. Putative membrane topology of the Tn10-encoded metal-tetracycline/H
؉ antiporter (TetA(B)). This structure was constructed on the basis of the results of hydropathy analysis (4) and our previous results of site-directed chemical modification of Cys mutants of TetA(B) (6) . Putative transmembrane segments are enclosed in squares. Graycolored squares indicate the transmembrane segments in which the precise boundaries were determined by our sitedirected chemical modification of cysteine-scanning mutants (7) (8) (9) . 2 The residues of the cysteine-scanning mutants constructed in this study are depicted as encircled letters. Encircled bold letters indicate structurally-important Gly-332 and second-site suppressor mutation sites, Ala-354 and Leu-30, reported previously (14) .
Mutagenesis of TM1 and TM11 in the Tetracycline/H
ϩ Antiporter38 mutants retained wild-type resistance. On the other hand, in the case of TM11 and its flanking regions, G336C completely lost the drug resistance (Table II) . Five mutants, G332C, Q335C, G346C, P350C, and Y357C, exhibited very low resistance ranging between 3.1 and 12.5 g/ml. Six other mutants, V339C, S340C, V347C, I363C, W364C, and G366C, showed moderate resistance (50 g/ml). [
C]NEM Binding to Cysteine-scanning Mutants of the Putative TM1
and Loop1-2 Region-On the basis of the hydropathy profile, TM1 was predicted to extend over 24 amino acid residues from Ile-7 to Leu-30 (4). Afterward, we slightly changed the length of TM1 from Ile-7 to Thr-28 because we found that the L29C and L30C mutants were highly reactive with NEM (20) . In this study, we investigated the NEM binding ability of 43 cysteine-scanning mutants, from N2C to G44C, in sonicated membrane vesicles (Fig. 2 ). There were no significant differences in the expression levels of these mutants (Fig. 2 , upper panels). As shown in Fig. 2 (lower panels) , K6C unexpectedly showed no reactivity with NEM and the T5C mutant. Thus, TM1 at the N-terminal end seems to start from Thr-5 instead of Ile-7. With respect to the C-terminal end of TM1, mutants M26C to T28C were all highly reactive with NEM. Therefore, it does not seem likely that Leu-29 is located at the boundary between TM1 and loop1-2. The region of TM1 is composed of 21 amino acid residues, from Thr-5 to Val-25. Regarding this region, three mutants, A16C, I19C, and M23C, were highly reactive with NEM. The G20C and P24C mutants were moderately reactive. The D15C and V25C showed low but significant reactivity with NEM. These residues are all located in the C-terminal half of TM1, indicating that only the Cterminal (periplasmic) half of TM1 may face a water-filled channel. Although NEM-reactive mutations occur every two residues from D15C to I22C, the terminal three mutations, M23C, P24C and V25C, were all reactive with NEM in greater or less degree, probably indicating that the terminal end of TM1 may protrude to the medium.
With respect to the putative loop1-2 region, out of 19 mutants, M26C to G44C, 14 showed high reactivity with NEM. Only five mutants, F33C, I34C, E37C, I39C, and N41C, were low reactive or not reactive with NEM, the direction of the side chains at these positions probably being inaccessible to NEM. It is of interest that the NEM-non-reactive positions were only in the downstream half of the putative loop1-2 region, probably reflecting some conformational difference between the upstream and downstream halves of this region. 14 C]NEM, and after solubilization, immunoprecipitation, and SDS-gel electrophoresis, the protein and radioactive bands were visualized by Coomassie Brilliant Blue staining (upper panels) and with a Bio-imaging Analyzer (lower panels), respectively, as described under "Experimental Procedures." [
14 C]NEM binding to the S4C and S36C mutants (6), the L29C and L30C mutants (21) , and the F43C and G44C mutants (9) was previously reported. cause we found that the Ala-354 mutant was highly reactive with NEM (14) . In this study, 39 cysteine-scanning mutants, Ser-328 to Gly-366, were analyzed. There were no significant differences in the expression levels of these mutants except for the P350C mutant, of which expression level was very low but certainly expressed (Fig. 3, upper panels) . Among them, the mutants upstream from G336C and those downstream from L361C showed high reactivity with NEM (Fig. 3, lower panels) . The NEM-non-reactive 17 mutants were clustered between L337C and S360C, indicating that the TM11 region comprises the 24 amino acid residues between Leu-337 and Ser-360. Seven mutants, V347C to F353C, exhibited no NEM reactivity, this region being the hydrophobic core of TM11. NEM-reactive mutations were periodically observed about every two residues at both ends of TM11. In an Edmandson wheel projection of TM11 (Fig. 4) , NEM-reactive mutants at the upstream (Fig.  4B , inner ring) and downstream (Fig. 4B, outer ring) ends of TM11 were located on the same side of the wheel. Considering the delay of the helix pitch at Pro-350 (22), the NEM-reactive sides at both ends were consistent with each other (Fig. 4) , indicating that both ends of TM11 face a water-filled channel on the same side. The central one-turn of the helix was embedded in the hydrophobic interior, suggesting that the central region may be pushed outward by helix bending due to the presence of a proline (Pro-350 Fig. 2. [ 14 C]NEM binding to the S328C, Y357C, S360C, and D365C mutants (6) and the A354C mutant (14) 
Mutagenesis of TM1 and TM11 in the Tetracycline/H
ϩ Antiporteravoid uncoupling, the prevention of [ 14 C]NEM binding by a membrane-impermeable maleimide derivative, AMS, in intact cells was investigated. TM1 is a partially amphiphilic helix, i.e. only the periplasmic half faces a channel. To our surprise, the A16C and I19C mutants were not accessible from the periplasmic side to AMS (Fig. 5A ), despite these positions being located in the periplasmic half of TM1. G20C was hardly reactive with NEM in intact cells, and NEM binding to M23C was prevented by AMS. Thus, the permeability barrier is present between Ile-19 and Met-23.
With respect to TM11, the NEM binding to Cys mutants downstream from A354C was prevented by AMS, whereas the binding to ones upstream from G346C was not affected by AMS in intact cells. Thus, the permeability barrier is present between Gly-346 and Ala-354, this region being the central hydrophobic core of TM11.
Cross-linking of Double-Cys Mutants Containing the A354C Mutation and Cys Mutation of Each of the Loop1-2
Residues-To reveal the proximity of TM1 and TM11 and to investigate the spacial relationship between loop1-2 and TM11, we constructed 22 double Cys mutants containing the A354C mutation and a Cys mutation at each of the loop1-2 residues starting from M23C, and disulfide cross-linking under oxidized conditions was detected as a mobility shift on SDS-polyacrylamide gel electrophoresis (Fig. 6) . Surprisingly, mobility-shift bands (30 kDa) under oxidized conditions were observed for most of these double-Cys mutants. When the SH groups of these mutants were masked with NEM before oxidation (NEMϩ, negative control), the band shifts were not observed. Therefore, the 30-kDa bands clearly indicated intermolecular disulfide cross-linking.
The M23C/A354C mutant gave a 30-kDa band, but the 
Mutagenesis of TM1 and TM11 in the Tetracycline/H
ϩ Antiporteramount was smaller than that of the 34-kDa band. In addition, it gave an unidentified 33-kDa minor band. On the other hand, the P24C/A354C mutant exhibited no cross-linking, and the V25C/A354C mutant exhibited a very low degree of cross-linking. In contrast, the L26C/A354C mutant exhibited a high degree of cross-linking formation (30 kDa/34 kDa band density ratio, about 2). Therefore, the TM1 helical structure seems to extend to Leu-26, in which four residues, Met-23 to Leu-26, may extrude to the periplasmic medium. The Met-23 and Leu-26 side of TM1 faces Ala-354, whereas Pro-24 and Val-25 are probably present on the opposite side of this helix. The remaining 18 double-Cys mutants exhibited high or moderate cross-linking, indicating that these residues comprise a flexible loop structure accessible to Cys-354. Among them, the doubleCys mutants involving A35C, S36C, and E37C each gave a significant 64-kDa band, corresponding to dimerization through intermolecular cross-linking. The mutants involving D38C, I39C, and A40C also exhibited weak dimerization. These six residues are probably located at the periphery of the loop structure. It may be surprising that SH groups introduced to these positions can simultaneously gain access to Cys-354 in the TM11 region in addition to those in the next molecule, probably reflecting the flexibility of loop1-2. The I34C, E37C, and I39C mutants efficiently formed cross-linking with A354C despite their low reactivity with NEM.
The Effect of Tetracycline on Disulfide Cross-linking Formation-To provide insight as to whether a substrate-induced conformational change involves a shift in the relative locations of TM1, loop1-2, and TM11, we investigated the effect of tetracycline on the disulfide cross-linking formation of some double-Cys mutants. As shown in Fig. 7 , the cross-linking formation of the M23C/A354C mutant was completely prevented by tetracycline, whereas those of the L30C/A354C and G44C/ A354C mutants were not affected. These results suggest that tetracycline caused the increase in the distance between the periplasmic ends of TM1 and TM11 or the alteration of the relative orientation of these transmembrane segments. It is interesting that the M23C/A354C mutant exhibited a 64-kDa dimer band due to the intermolecular cross-linking when it was oxidized in the presence of tetracycline (Fig. 7) . Since the other two double-Cys mutants involving the A354C mutation showed no dimer band, M23C was responsible for the tetracycline-induced intermolecular cross-linking, indicating a possibility that the side chain at position 23 became oriented to periphery of the helix bundle by substrate-induced conformational change.
DISCUSSION
The results of this study are schematically summarized in Fig. 8 . TM1 comprises 21 residues, Thr-5 to Val-25, in which three residues, Met-23 to Val-25, may protrude to the periplasmic medium, and TM11 comprises 24 residues, Leu-337 to Ser-360. NEM-reactive Cys mutations of TM1 periodically occur only in the periplasmic half of this helix, indicating that only the periplasmic half of TM1 faces a water-filled channel. On the other hand, NEM-reactive mutations of TM11 periodically occur over the whole length except for the central hydrophobic core. Pro-350 is located in the middle of the core. Thus, TM11 seems to bend at Pro-350, and the central part may project into the hydrophobic interior. The break in the waterfilled channel is located close to the periplasmic end of TM1. On the other hand, it is located in the central hydrophobic core of TM11. We observed that the permeability barrier is located in the middle of the membrane in TM5. 2 There are two possibilities for the reason why the permeability barrier is located close to the periplasmic end of TM1, as follows. 1) The cytoplasmic portion of the water channel extends along TM1, or 2) the length of TM1 at the periplasmic end may be underestimated.
On the basis of the current results, TM2 is close to TM11, similar to or rather than TM1 because G44C and F43C, which are located at the periplasmic end of TM2 (9) , were more efficiently cross-linked with A354C than M23C. TM2 also faces a water-filled channel along its whole length (9) . Thus, the channel wall is mainly composed of TM2 (9), TM5, 2 and TM11. Another channel wall constituent candidate is TM8, which contains His-257 (23). Now we are analyzing cysteine-scanning mutants of TM8. TM1 seems to partly face the channel. Loop1-2 is located at the exit of the channel and, thus, forms a conformational-sensitive domain (14) . Kaback et al. (24) and Goswitz and Brooker (25) independently present a model of the helix arrangement of lactose permease, based on the results of cross-linking experiments and second-site suppressor mutation, respectively. Although the helix arrangements of lactose permease in their models are greatly different from each other, TM11 is placed next to TM2 in both models (24, 25) . In the model of Goswitz and Brooker (25) , TM1 is placed across the substrate translocation channel from TM11. If cross-linking does occur across the channel, our result is very similar to their model, suggesting the structural similarity between major facilitator superfamily-type symporters and antiporters.
The cross-linking formation between the periplasmic ends of TM1 and TM11 was prevented by tetracycline; however, those between TM2 and TM11 and between loop1-2 and TM11 were not affected. These observations also supported the idea that the substrate translocation channel is located between TM1 and TM11, and the periplasmic end of TM1 may be related to the substrate-induced gating function.
